Subscribe
The first nonprescription, OTC naloxone nasal spray (Narcan) was approved by the FDA in March 2023.
Telehealth-Based OUD Treatment May Lead to Better Health, Obstetric Outcomes Among Pregnant Patients
1.0 Credits / Lung Cancer, Oncology
1.0 Credit / Law
1.0 Credits / Oncology
1.5 Credits / HIV/AIDS
1.0 Credits / Cardiology
1.5 Credits / Immunization, Infectious Disease
1.0 Credits / Neurology
1.0 Credits / Dermatology, Immunology
1.0 Credits / Neurology, Psychiatry
1.0 Credit / Immunology, Nephrology
1.0 Credit / Immunization, Infectious Disease
1.0 Credits / Immunization, Infectious Disease
1.0 Credits / Breast Cancer, Oncology, Patient Safety, Women's Health
1.5 Credits / Breast Cancer, Oncology
1.5 Credits / Genitourinary Cancer, Men's Health, Oncology
1.0 Credit / Ophthalmology/Optometry
1.5 Credits / Cardiology, Rare Diseases
1.5 Credits / Cardiology, Endocrinology, Diabetes & Metabolism, Nephrology
1.0 Credit / Oncology, Lung Cancer
1.0 Credit / Ophthalmology
1.0 Credit / Rheumatology
1.5 Credit / Neurology
1.5 Credit / Immunology
1.5 Credit / Ophthalmology/Optometry
1.0 Credit / Gastrointestinal Cancer, Oncology
1.0 Credit / Urology
1.5 Credits / Endocrinology, Diabetes & Metabolism, Rare Diseases
1.0 Credit / Breast Cancer, Oncology, Women's Health
1.0 Credit / Pulmonology/Respiratory
1.0 Credit / Hematologic Cancer, Oncology
1.0 Credit / Breast Cancer, Endocrinology, Diabetes & Metabolism, Oncology, Patient Safety, Women's Health
1.0 Credit / Hematologic Cancer, Hematology, Law, Oncology
1.0 Credit / Oncology
1.0 Credit / Gynecologic Cancer, Oncology, Women's Health
1.25 Credit / Lung Cancer, Oncology, Pathology
1.0 Credit / Hematologic Cancer, Hematology, Oncology
1.5 Credit / Pulmonology